Nov 5
AFJKU · Aimei Health Technology Co., Ltd.
$12.89
At close · Nov 3
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with the Company's assessment of going concern considerations in accordance with Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined that if the Company is unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of the Initial Public Offering, the requirement that the Company cease all operations, redeem the Public Shares, and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern within one year after the date that the unaudited financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$38.63M
Shares
3.17M
Volume · Nov 3
605
Avg daily vol (17 sessions)
2611
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$12.89
Open$12.21
Day$12.21–12.89
52W close$8.03–75.37
Avg vol 30d3K
Short int233 · 0.0% of shares · 1.0d
Short vol100%
DataDec 2023–Nov 2026
Filing10-Q · Aug 13
Latest documents
2026
Nov 3
Current report
8-K/A
Events of Oct 5
New debt or off-balance-sheet obligation
Aimei Health Technology Co., Ltd. amended its October 5, 2026 disclosure solely to remove United Hydrogen from the promissory-note description, while extending its business-combination deadline to November 6, 2026 with a $34,330.96 note to Aimei Investment Ltd.
Oct 19
Proxy statement
DEF 14A
Proxy statement
Aimei Health Technology is seeking shareholder approval at a November 10, 2026 EGM to amend its Articles and Trust Agreement, extending the business combination deadline from December 6, 2026 to December 6, 2027, after its United Hydrogen deal was terminated on July 7, 2026.
Oct 9
Proxy statement
PRE 14A
Proxy statement
Aimei Health seeks shareholder approval to extend its business-combination deadline from December 6, 2026 to December 6, 2027 after the United Hydrogen Group Inc. agreement was terminated on July 7, 2026.
Oct 5
Current report
8-K
New debt or off-balance-sheet obligation
Aimei Health Technology Co., Ltd. deposited $34,330.96 to extend its business-combination deadline from October 6, 2026 to November 6, 2026 and issued Aimei Investment Ltd an unsecured, noninterest-bearing promissory note convertible at $10.00 per unit.
Technicals
trend & momentum for long-term holders illustrative — not investment adviceMarket signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
7 of 21 funds reported for Sep 30 · net -201.4K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.01% of shares out · ▲ +27.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
21 holders — near 2-yr low, contrarian setup
Price context
position in its 52-week range
Range low $8
Now $13 · 7%
Range high $75
vs 50-day avg -61%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AFJKU
this stock
Aimei Health Technology Co., Ltd.
|
$38.63M | -80.5% | — | — | — |
|
VYLR
Vylor Inc.
|
$46.80B | — | — | — | 2.2% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$650.38M | +3.1% | — | — | 0.0% |
|
CCXI
Churchill Capital Corp XI
|
$627.18M | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
20
- % held
- 145.1%
- Reported
- 7 of 21
- Top holder
- HIGHBRIDGE CAPITAL MANAGE…
Held
Float
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AFJKU | -4.5% | -11.8% | +24.3% | +7.3% | -80.5% |
| SPY | -2.0% | -3.2% | +1.6% | -0.2% | +10.6% |
| vs SPY | -2.5% | -8.6% | +22.7% | +7.5% | -91.1% |
Key facts
CIK
1979005
CUSIP
G01341109